Seach Medical Group Ltd
TASE:SEMG
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
128.6
282.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches ILS.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Seach Medical Group Ltd
Cost of Revenue
Seach Medical Group Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Seach Medical Group Ltd
TASE:SEMG
|
Cost of Revenue
-₪119.9m
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-81%
|
CAGR 10-Years
-58%
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Cost of Revenue
-$8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
InterCure Ltd
TASE:INCR
|
Cost of Revenue
-₪247.2m
|
CAGR 3-Years
-93%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-63%
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Cost of Revenue
-$17.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-35%
|
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Cost of Revenue
-₪248.9m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-3%
|
|
Seach Medical Group Ltd
Glance View
Seach Medical Group Ltd. engages in medical cannabis field. The main acitivity of the Company is focused on cultivation, breeding, production and marketing of medical cannabis products.
See Also
What is Seach Medical Group Ltd's Cost of Revenue?
Cost of Revenue
-119.9m
ILS
Based on the financial report for Jun 30, 2024, Seach Medical Group Ltd's Cost of Revenue amounts to -119.9m ILS.
What is Seach Medical Group Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-58%
Over the last year, the Cost of Revenue growth was -20%. The average annual Cost of Revenue growth rates for Seach Medical Group Ltd have been -79% over the past three years , -81% over the past five years , and -58% over the past ten years .
You don't have any saved screeners yet
